Skip to main content

memo - Magazine of European Medical Oncology OnlineFirst articles

21.02.2018 | short review Open Access

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

The treatment of newly diagnosed multiple myeloma has changed dramatically over the past 20 years, from near uniform application of chemotherapy to a patient performance status- and risk-based approach. Furthermore, initiation of treatment …

21.02.2018 | short review

Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer

The STAMPEDE and CHAARTED trials brought about practice-changing innovation in the management of patients with metastatic, castration-naive prostate cancer (CNPC). These trials reported a clinically meaningful overall survival benefit of …

21.02.2018 | review

Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood

Survival after childhood cancer has improved substantially; therefore, the number of childhood cancer survivors is increasing. This growing population of childhood cancer survivors, however, is at risk of a spectrum of adverse health outcomes.

21.02.2018 | case report Open Access

Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity

Multiple myeloma (MM) is a clonal plasma cell neoplasm accounting for 1% of all malignancies in the United States and 10% of hematological malignancies [ 1 ]. The current literature continues to describe a few cases of infiltrative myelomatous …

16.02.2018 | comment Open Access

ESMO 2017—my personal highlights

This article is not intended to be a comprehensive review of all highlights presented at the recent ESMO Annual Meeting, but rather a summary from a personal point of view in three very different fields of oncology. Breast cancer and lung cancer …

Aktuelle Ausgaben

Über diese Zeitschrift

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

Weitere Informationen